PharmacovigilanceOfficial

CMS extends nationwide freeze on new Medicare hospice and home health enrolment

🇺🇸 CMS · Thu 12 Nov 2026

The US agency is prolonging, with modifications, its moratoria on new hospice and home health agency enrolment by six months, citing fraud, waste and abuse.

The Centers for Medicare & Medicaid Services (CMS) announced on 12 November 2026 that it is extending its nationwide moratoria on new Medicare enrolment of hospices and home health agencies for a further six months. The agency says the step is intended to curb fraud, waste and abuse in the programme.

CMS has also modified the moratoria as part of the extension. The material available to VigiEye does not specify what the modifications are, and the full text of the notice was not available at the time of writing. Providers and advisers should consult the CMS notice directly for the exact scope, conditions and any exemptions.

The measure is a programme-integrity action. It has no direct pharmacovigilance or product-safety content and does not concern medicines or medical devices regulation.

What it means for your team

  • Organisations planning to enter the US Medicare hospice or home health market should check the full CMS notice for the revised terms before making enrolment plans.
  • The modifications are not described in the information available, so no assumptions should be made about exemptions or changes in scope.
  • Pharmacovigilance and quality teams are not directly affected, as the action concerns provider enrolment rather than product safety.

Official source: CMS ↗

Article written by VigiEye from the official source (CMS). AI-assisted; check the source before acting.

More Pharmacovigilance All →